1. Home
  2. HLN

HLN

Haleon plc (Each representing two)

Logo Haleon plc (Each representing two)

Consumer Discretionary

Package Goods/Cosmetics

Nasdaq

as 04-16-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Founded: 2022 Country:
United Kingdom
United Kingdom
Employees: 24622 City: N/A
Market Cap: 36.8B IPO Year: N/A
Target Price: $9.50 AVG Volume (30 days): 5.9M
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield: 1.85% Dividend Payout Frequency: Semi-Annual
EPS: 0.28 EPS Growth: -8.87
52 Week Low/High: $7.70 - $9.05 Next Earning Date: 02-29-2024
Revenue: $14,306,329,114 Revenue Growth: 14.25%
Revenue Growth (this year): 4.14% Revenue Growth (next year): 4.35%

Share on Social Networks: